| Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition) J Zhou, H Sun, Z Wang, W Cong, J Wang, M Zeng, W Zhou, P Bie, L Liu, ... Liver cancer 9 (6), 682-720, 2020 | 598 | 2020 |
| Guidelines for diagnosis and treatment of primary liver cancer in China (2017 Edition) J Zhou, HC Sun, Z Wang, WM Cong, JH Wang, MS Zeng, JM Yang, P Bie, ... Liver cancer 7 (3), 235-260, 2018 | 552 | 2018 |
| Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes HY Pan, L Guo, Q Li Diabetes research and clinical practice 88 (1), 29-33, 2010 | 490 | 2010 |
| Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression X Huang, Z Li, Q Zhang, W Wang, B Li, L Wang, Z Xu, A Zeng, X Zhang, ... Molecular cancer 18, 1-20, 2019 | 334 | 2019 |
| Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open … D Yue, S Xu, Q Wang, X Li, Y Shen, H Zhao, C Chen, W Mao, W Liu, J Liu, ... The Lancet Respiratory Medicine 6 (11), 863-873, 2018 | 293 | 2018 |
| Variable intra-tumor genomic heterogeneity of multiple lesions in patients with hepatocellular carcinoma R Xue, R Li, H Guo, L Guo, Z Su, X Ni, L Qi, T Zhang, Q Li, Z Zhang, ... Gastroenterology 150 (4), 998-1008, 2016 | 211 | 2016 |
| The phytochemical, EGCG, extends lifespan by reducing liver and kidney function damage and improving age‐associated inflammation and oxidative stress in healthy rats Y Niu, L Na, R Feng, L Gong, Y Zhao, Q Li, Y Li, C Sun Aging cell 12 (6), 1041-1049, 2013 | 179 | 2013 |
| MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7 Q Li, C Zou, C Zou, Z Han, H Xiao, H Wei, W Wang, L Zhang, X Zhang, ... Cancer letters 335 (1), 168-174, 2013 | 152 | 2013 |
| Lidocaine Induces Apoptosis and Suppresses Tumor Growth in Human Hepatocellular Carcinoma Cells In Vitro and in a Xenograft Model In Vivo W Xing, DT Chen, JH Pan, YH Chen, Y Yan, Q Li, RF Xue, YF Yuan, ... Anesthesiology 126 (5), 868-881, 2017 | 149 | 2017 |
| Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma X Shen, N Li, H Li, T Zhang, F Wang, Q Li Journal of cancer research and clinical oncology 136, 1745-1754, 2010 | 140 | 2010 |
| Higher vaspin levels in subjects with obesity and type 2 diabetes mellitus: a meta-analysis R Feng, Y Li, C Wang, C Luo, L Liu, F Chuo, Q Li, C Sun Diabetes research and clinical practice 106 (1), 88-94, 2014 | 139 | 2014 |
| Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice W Zhang, HC Sun, WQ Wang, QB Zhang, PY Zhuang, YQ Xiong, XD Zhu, ... Gastroenterology 143 (6), 1641-1649. e5, 2012 | 121 | 2012 |
| Resveratrol reduces acute lung injury in a LPS‑induced sepsis mouse model via activation of Sirt1 Retraction in/10.3892/mmr. 2023.13137 T Li, J Zhang, J Feng, Q Li, L Wu, Q Ye, J Sun, Y Lin, M Zhang, R Huang, ... Molecular medicine reports 7 (6), 1889-1895, 2013 | 109 | 2013 |
| Lower serum 25 (OH) D concentrations in type 1 diabetes: a meta-analysis R Feng, Y Li, G Li, Z Li, Y Zhang, Q Li, C Sun Diabetes research and clinical practice 108 (3), e71-e75, 2015 | 107 | 2015 |
| MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating Q Tang, Z Zou, C Zou, Q Zhang, R Huang, X Guan, Q Li, Z Han, D Wang, ... Tumor Biology 36, 1701-1710, 2015 | 104 | 2015 |
| Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition) HC Sun, J Zhou, Z Wang, X Liu, Q Xie, W Jia, M Zhao, X Bi, G Li, X Bai, ... Hepatobiliary surgery and nutrition 11 (2), 227, 2022 | 102 | 2022 |
| Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases C Fang, J An, A Bruno, X Cai, J Fan, J Fujimoto, R Golfieri, X Hao, H Jiang, ... Hepatology international 14, 437-453, 2020 | 101 | 2020 |
| Astragaloside IV and cycloastragenol are equally effective in inhibition of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in the endothelium Y Zhao, Q Li, W Zhao, J Li, Y Sun, K Liu, B Liu, N Zhang Journal of Ethnopharmacology 169, 210-218, 2015 | 101 | 2015 |
| Regulatory MiR‐148a‐ACVR1/BMP circuit defines a cancer stem cell‐like aggressive subtype of hepatocellular carcinoma L Li, Y Liu, Y Guo, B Liu, Y Zhao, P Li, F Song, H Zheng, J Yu, T Song, ... Hepatology 61 (2), 574-584, 2015 | 97 | 2015 |
| Inhibiting effect of Astragalus polysaccharides on the functions of CD4+ CD25highTreg cells in the tumor microenvironment of human hepatocellular carcinoma LI Qiang, J Bao, X Li, T Zhang, X Shen Chinese Medical Journal 125 (5), 786-793, 2012 | 95 | 2012 |
